Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MAPK1 R135K
i
Other names:
MAPK1, ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2, Mitogen-activated protein kinase 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5594
Related biomarkers:
Expression
Mutation
‹
›
Associations
(1)
News
Trials
Filter by
Latest
5years
Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma. (PubMed, NPJ Genom Med)
Residues D321, R135, and E322 are in 3D proximity. MAPK1p.D321N drives marked in vivo erlotinib sensitivity, while p.R135K's effect is moderate.
5 years ago
Journal
|
MAPK1 (Mitogen-activated protein kinase 1)
|
MAPK1 R135K
|
erlotinib
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.